K Number
K102011
Date Cleared
2010-09-03

(49 days)

Product Code
Regulation Number
892.5050
Panel
RA
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments for patients with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal irradiation (brachytherapy) treatments. In addition, the Eclipse Proton Eye algorithm is specifically indicated for planning proton treatment of neoplasms of the eye.

Device Description

The Varian Eclipse™ Treatment Planning System (Eclipse TPS) provides software tools for planning the treatment of malignant or benign diseases with radiation. Eclipse TPS is a computerbased software device used by trained medical professionals to design and simulate radiation therapy treatments. Eclipse TPS is capable of planning treatments for external beam irradiation with photon, electron, and proton beams, as well as for internal irradiation, (brachytherapy) treatments.

AI/ML Overview

The provided text describes the Eclipse Treatment Planning System (Eclipse TPS) and compares its features to a predicate device. However, it does not contain a study or data proving the device meets specific acceptance criteria in the context of a clinical performance evaluation.

Instead, the document is a Premarket Notification 510(k) Summary for the Eclipse TPS, which focuses on demonstrating substantial equivalence to a legally marketed predicate device. This is a regulatory submission process, not a clinical study.

Here's a breakdown of why the requested information cannot be fully provided from the given text:

  • No "Acceptance Criteria" as clinical performance metrics: The table presented in the document is a "Substantial Equivalence Comparison Chart" which outlines features and functionalities of the Eclipse TPS and compares them to its predicate device. These are design and functional specifications, not clinical acceptance criteria with performance targets (e.g., sensitivity, specificity, accuracy, or reader agreement).
  • No "Study" in the sense of a clinical trial: The document does not describe any clinical study, experimental design, or results that evaluate the device's performance against clinical endpoints. The "study" mentioned here refers to the 510(k) submission process itself, which relies on demonstrating equivalence rather than proving de novo clinical performance.

Therefore, for aspects related to "acceptance criteria," "study," "sample size," "experts," "ground truth," "MRMC," and "standalone performance," the information is not available in the provided text.

Here's what can be extracted based on the nature of the document:


1. Table of Acceptance Criteria and Reported Device Performance

As explained above, the provided document does not present clinical acceptance criteria with performance metrics. Instead, it provides a "Substantial Equivalence Comparison Chart" detailing functional specifications and comparing the proposed device (Eclipse TPS) to a predicate device (Eclipse Treatment Planning System, K091492).

Feature/CharacteristicAcceptance Criteria (Predicate)Reported Device Performance (Eclipse TPS)
Indication for UseSee aboveSee above
General Usage
External beam PHOTON planningyesyes
External beam PHOTON inverse planningyesyes
External beam ELECTRON planningyesyes
External beam PROTON planningyesyes
External beam OCULAR PROTON planningyesyes
Internal BRACHYTHERAPY planningyesyes
Stereotactic Frame Localizationyesyes
Supported External Beams & Accessories
Photon beamsyesyes
Electron beamsyesyes
Proton beamsyesyes
Coplanar fieldsyesyes
Non-coplanar fieldsyesyes
Multi-leaf Collimatorsyesyes
Asymmetric collimatorsyesyes
Stereotactic Cone collimatorsyesyes
Arc fieldsyesyes
Poured Blocksyesyes
Compensatorsyesyes
Physical wedgesyesyes
Dynamic wedgesyesyes
Rotating treatment couchyesyes
Supported Brachytherapy Sources & Accessories
Plan for high dose rate afterloaderyesyes
Manual low dose rate brachytherapy:
seeds, line sources, wireyesyes
Applicator libraryyesyes
Needle templatesyesyes
Graphical User Interface
Multiple-instance applicationyesyes
Multiple-workspace layoutyesyes
Graphical display/editing of field parametersyesyes
Beam's-Eye-View displayyesyes
3D patient image displayyesyes
Model for human Eyeyesyes
SRS Localization applicationyesyes
SRS Planning applicationyesyes
Biological Optimization applicationyesyes
Biological Evaluation applicationyesyes
3D Conformal Optimization applicationyesyes
Image Processing
Orthogonal image displays (3)yesyes
Oblique image displayyesyes
Edge enhancement filtersyesyes
Image smoothing filtersyesyes
CT/MR/PET Image Registrationyesyes
Image blending utilityyesyes
4D image display (registration of time series of 3D images)yesyes
Digitally reconstructed radiographsyesyes
Enclosed Volume measurementyesyes
Stereotactic Frame Coordinate transformationyesyes
Image Segmentation
Geometrical shapesyesyes
Manual editing and manipulation toolsyesyes
Automatic /semi-automatic toolsyesyes
Automatic/semi-automatic on-demand and post-processing tools for individual organs/structuresyesyes
Automatic on-demand and pre-processing tools for multiple organs/structuresyesyes
3D Automarginyesyes
Logical operatorsyesyes
Dose Calculation
Distributed Calculation Frameworkyesyes
Photon calculationyesyes
Energy Range (Photon)1 MV - 50 MV1 MV - 50 MV
CT-based volumetric calculationyesyes
Non-CT based IRREG calculationyesyes
Convolution methodyesyes
Combined electron/photon scatteryesyes
Directional heterogeneity correctionyesyes
Treatment head modelingyesyes
Photon Monitor Unit calculationyesyes
Beam Angle Optimization (GEOS)yesyes
Leaf Motion Sequencingyesyes
Dose Dynamic Arc planningyesyes
Cone Dose Calculationyesyes
Biological optimizationyesyes
3D Conformal Optimizationyesyes
AcurosXB dose calculation algorithmnoyes
Electron calculationyesyes
Energy Range (Electron)1 MeV - 50 MeV1 MeV - 50 MeV
Gaussian Pencil Beam Modelyesyes
Electron Monte Carlo algorithmyesyes
Electron Monitor Unit calculationyesyes
Proton calculationyesyes
Energy Range (Proton)50 MeV - 300 MeV50 MeV - 300 MeV
Brachytherapy calculationyesyes
AAPM TG 43 compliantyesyes
Point Dose calculationyesyes
Optimization to point dose constraintsyesyes
Geometric optimizationyesyes
Acuros dose calculation algorithmyesyes
Eclipse Algorithm Application Programming Interface (EAAPI)noyes
Dose Evaluation
Dose color wash2D, 3D2D, 3D
Isodose levels2D, 3D2D, 3D
Isodose Surface3D3D
Reference point dose summaryyesyes
Dose Volume Histogram plotyesyes
Plan summing toolyesyes
Plan comparison toolsyesyes
Evaluation using biological modelsyesyes
Plan Output - Hardcopy
Graphics window screen dumpyesyes
Patient administration datayesyes
Plan parametersyesyes
Geometrical displays of plan datayesyes
Dose distributionyesyes
DVH plotyesyes
BEV displayyesyes
Patient orientationyesyes
User Configurable hardcopy layoutsyesyes
Import/Export Interfaces
VARIS/Vision database integrationyesyes
DICOM RT / 3.0yesyes
Other image formatsyesyes
Electromagnetic Digitizerimportimport
Film Scannerimportimport
Export field coordinates to Laser Systemexportexport

2. Sample size used for the test set and the data provenance:

  • Sample size: Not applicable/not provided. This document doesn't describe a clinical test set or study.
  • Data provenance: Not applicable/not provided.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

  • Not applicable/not provided.

4. Adjudication method for the test set:

  • Not applicable/not provided.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

  • No MRMC study was done/reported in this document. The device is a treatment planning system, not an AI-assisted diagnostic device for human readers.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

  • Not applicable/not provided as a standalone performance study. The document focuses on the functional equivalence of the entire system for treatment planning, which inherently involves human professional users.

7. The type of ground truth used:

  • Not applicable/not provided in the context of a performance study. For regulatory purposes, the "ground truth" for substantial equivalence is the predicate device's established performance and specifications.

8. The sample size for the training set:

  • Not applicable/not provided. This document is not describing a machine learning or AI algorithm development study that would involve a training set.

9. How the ground truth for the training set was established:

  • Not applicable/not provided.

§ 892.5050 Medical charged-particle radiation therapy system.

(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.